Shionogi & Co., Ltd. And Nippon Kayaku Co., Ltd. To Release Cetrotide In Japan
9/21/2006 3:44:33 PM
More...
|
AEterna Laboratories Inc. (AELA) / Zentaris GmbH (AELA) To Present Today Additional Detailed Positive Phase II Data On Cetrorelix In Gynecological Indications At The 18th World Congress Of The International Federation Of Fertility Societies (IFFS)
10/19/2005 5:11:29 PM
More...
|
AEterna Laboratories Inc./Zentaris GmbH (AELA) (AELA) To Present Detailed Positive Phase II Data On Cetrorelix And New Preclinical Data On Perifosine During Investor And Analyst Day In New York City
10/19/2005 5:11:22 PM
More...
|
Spectrum Pharmaceuticals (SPPI) Licenses A Fourth-Generation Phase 2 LHRH Antagonist From Zentaris GmbH (AELA)
10/19/2005 5:11:07 PM
More...
|
AEterna Laboratories Inc. / Zentaris GmbH And Solvay Pharmaceuticals, Inc. Report Headline Positive Data From Six Phase II Trials Of Cetrorelix In Three Indications: Endometriosis, Uterine Myomas And Benign Prostatic Hyperplasia
10/19/2005 5:11:05 PM
More...
|
AEterna Laboratories Inc. (AELA) Subsidiary Zentaris GmbH (AELA) Announces Initiation Of Dose Ranging Study For A Novel Oral Agent That Stimulates Growth Hormone Secretion
10/19/2005 5:10:59 PM
More...
|
AEterna Laboratories Inc. (AELA) Expands Pipeline As Zentaris Subsidiary Establishes New Research Collaborations With University Laboratories In France, Germany And Italy
10/19/2005 5:10:25 PM
More...
|
AEterna Laboratories Inc. (AELA) Through Its Subsidiary Zentaris GmbH (AELA) Signs Partnership With Roche (RHHBY) In Brazil For New Treatment Of Leishmaniasis, A Devastating Tropical Disease
10/19/2005 5:09:52 PM
More...
|
AEterna Laboratories Inc. (AELA) Subsidiary Zentaris AG (AELA) And Solvay Pharmaceuticals, Inc. Sign Extensive Collaboration Agreement
10/19/2005 5:09:47 PM
More...
|